Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia

Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia

Mostra altre versioni (1)

<p style="text-align:justify;"> <b>Background:</b> Mycoplasma pneumoniae (M. pneumoniae) is a significant cause of community‐acquired pneumonia in children and adolescents. Treatment with macrolide antibiotics is recommended. However, M. pneumoniae is difficult to diagno...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Wang, K, Gill, P, Perera, R, Thomson, A, Mant, D, Harnden, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	Wiley 2012

Documenti analoghi

Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.
di: Wang, K, et al.
Pubblicazione: (2012)

Macrolide-resistant <it>Mycoplasma pneumoniae</it> in adolescents with community-acquired pneumonia
di: Miyashita Naoyuki, et al.
Pubblicazione: (2012-05-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
di: Abdul-Rahman Mamdouh Mohammad, et al.
Pubblicazione: (2020-12-01)

Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia
di: Mingyu Tang, et al.
Pubblicazione: (2021-02-01)

Evaluation of real-time PCR with serology for diagnosis of community acquired pneumonia caused by Mycoplasma pneumoniae
di: Anand Manoharan, et al.
Pubblicazione: (2022-07-01)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
di: Yu-Chin Chen, et al.
Pubblicazione: (2020-07-01)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
di: Merida-Vieyra J, et al.
Pubblicazione: (2019-04-01)

<it>Mycoplasma pneumoniae </it>pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ)
di: Lück Christian, et al.
Pubblicazione: (2009-05-01)

Severe community-acquired pneumonia caused by Mycoplasma pneumoniae in young female patient
di: Milačić Nena, et al.
Pubblicazione: (2015-07-01)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
di: Fei Li, et al.
Pubblicazione: (2022-04-01)

Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis.
di: Wang, K, et al.
Pubblicazione: (2011)

Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in england: A retrospective analysis
di: Wang, K, et al.
Pubblicazione: (2011)

Adenovirus and Mycoplasma pneumoniae co-infection as a risk factor for severe community-acquired pneumonia in children
di: Qihong Chen, et al.
Pubblicazione: (2024-01-01)

Diagnosis and Treatment of Community-Acquired Pneumonia in Children
di: I.A. Karymdzhanov, et al.
Pubblicazione: (2016-02-01)

Diagnosis and treatment of community-acquired pneumonia in children
di: I.A. Karimdzhanov, et al.
Pubblicazione: (2024-09-01)

Pneumonia adquirida na comunidade e derrame pleural parapneumônico relacionados a Mycoplasma pneumoniae em crianças e adolescentes Mycoplasma pneumoniae-related community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents
di: Letícia Alves Vervloet, et al.
Pubblicazione: (2012-04-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
di: Mansoreh Momen Heravi, et al.
Pubblicazione: (2023-12-01)

Symptom Resolution in Patients with Mycoplasma pneumoniae Pneumonia
di: Thomas J Marrie, et al.
Pubblicazione: (2004-01-01)

Survey of macrolide-resistant Mycoplasma pneumoniaein children with community-acquired pneumonia in Switzerland
di: Patrick M. Meyer Sauteur, et al.
Pubblicazione: (2014-09-01)

Clinical characteristics and serum inflammatory markers of community‐acquired mycoplasma pneumonia in children
di: Fei Fan, et al.
Pubblicazione: (2023-07-01)

Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
di: Roger Dumke, et al.
Pubblicazione: (2015-03-01)

Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias
di: Letícia Alves Vervloet, et al.

Mycoplasma pneumoniae pneumonia – challenges related to diagnosis and treatment in children
di: Nicoleta-Ana Tomsa, et al.
Pubblicazione: (2024-03-01)

FEATURES OF THE OUTBREAK OF THE COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY MYCOPLASMA PNEUMOINIAE AT CHILDREN IN KHABAROVSK REGION
di: O. E. Guseva, et al.
Pubblicazione: (2018-02-01)

Commentary: Adenovirus and Mycoplasma pneumoniae co-infection as a risk factor for severe community-acquired pneumonia in children
di: Duc Long Phi, et al.
Pubblicazione: (2024-12-01)

Surge in Mycoplasma Pneumoniae infection and Respiratory Viruses Co-infection in Children With Community-Acquired Pneumonia in the Post-Pandemic
di: Chi J, et al.
Pubblicazione: (2024-09-01)

Impact of COVID-19 on the Epidemiological Features of Mycoplasma pneumoniae Infection in Children with Community-Acquired Pneumonia in Henan, China
di: Lifeng Li, et al.
Pubblicazione: (2023-02-01)

Signs and symptoms indicative of community-acquired pneumonia in infants under six months
di: Maria de Fátima Bazhuni Pombo March, et al.

British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.
di: Harris, M, et al.
Pubblicazione: (2011)

Retrospective survey for sialidase activity in <it>Mycoplasma pneumoniae </it>isolates from cases of community-acquired pneumonia
di: Brown Daniel R, et al.
Pubblicazione: (2011-06-01)

Prevalence of Genomic Resistance to Macrolide in Mycoplasma Isolates among Children with Community Acquired Pneumonia
di: Sivasambo Kalpana, et al.
Pubblicazione: (2022-10-01)

Community-acquired pneumonia in children; the challenges of microbiological diagnosis
di: Rodrigues, C, et al.
Pubblicazione: (2017)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
di: Vinod H. Ratageri, et al.
Pubblicazione: (2022-04-01)

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
di: Lanqin Chen, et al.
Pubblicazione: (2023-03-01)

Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children
di: Xue Zhang, et al.
Pubblicazione: (2024-01-01)

Detection of Mycoplasma pneumoniae in hospitalized children with pneumonia in Laos
di: Vilivong, K, et al.
Pubblicazione: (2024)

Community-acquired pneumonia. Diagnosis, treatment approaches
di: A. A. Anderzhanova, et al.
Pubblicazione: (2019-08-01)

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
di: Xie Q, et al.
Pubblicazione: (2022-11-01)

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
di: Beilei Yang, et al.
Pubblicazione: (2021-08-01)

AMOXYCILLIN FOR COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN
di: A. B. MALAKHOV, et al.
Pubblicazione: (2017-07-01)